What is the Global Health PE ratio today?
Global Health's PE ratio is 62.8 at the 29 October 2026 close (₹1,299.70 a share): a market capitalisation of ₹34,932 crore divided by consolidated net profit attributable to shareholders of ₹556 crore over the last four quarters (Q2 FY26 to Q1 FY27).
What is the Global Health debt to equity ratio?
Global Health's debt-to-equity ratio was 0.30 on 31 March 2026: borrowings of ₹1,190 crore against total equity of ₹3,984 crore. A year earlier, on 31 March 2025, it was 0.10.
What is the Global Health net worth?
Global Health's net worth — shareholders' equity in its consolidated balance sheet — was ₹3,962 crore on 31 March 2026, up 17.0% from ₹3,386 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹34,932 crore at the 29 October 2026 close.
What is the Global Health PB ratio (price to book value)?
Global Health's price-to-book (PB) ratio is 8.82 at the 29 October 2026 close: a market capitalisation of ₹34,932 crore divided by shareholders' equity (book value) of ₹3,962 crore on 31 March 2026. That is a book value of ₹147.40 per share against a share price of ₹1,299.70.
What is the Global Health book value per share?
Global Health's book value per share was ₹147.40 on 31 March 2026: shareholders' equity of ₹3,962 crore divided by the 26.88 crore shares in issue, up 16.9% from ₹126.08 a year earlier. The share price at the 29 October 2026 close was ₹1,299.70.
What is the Global Health shareholding pattern?
On 30 September 2026, Global Health's shares were held by promoters 33.00%, foreign portfolio investors (FII/FPI) 9.91%, domestic institutions (DII) 17.01% (including mutual funds at 15.97%) and retail and other non-institutional investors 39.97%. Over the year, FII holding was down 1.49 percentage points from 11.40% and DII holding was up 4.03 percentage points from 12.98%.
What is the Global Health market cap?
Global Health's market capitalisation was ₹34,932 crore at the 29 October 2026 close: 26.88 crore shares at ₹1,299.70 each.
What is the Global Health dividend in 2026 and its record date?
In 2026, Global Health has declared one dividend: ₹0.50 with record date 14 August 2026.
When are the Global Health next results?
Global Health will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, the date of the board meeting it has notified to the exchanges.
Is Global Health debt free?
No. Global Health had borrowings of ₹1,190 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.30. Its cash and current investments were ₹1,130 crore, so its net debt was ₹59.8 crore.
What is the Global Health dividend yield?
Global Health's dividend yield is 0.04% at the 29 October 2026 close: dividends of ₹0.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹1,299.70. They were ₹0.50 on 14 August 2026.
What is the Global Health promoter holding?
Promoters held 33.00% of Global Health on 30 September 2026, unchanged from the previous quarter and down 0.01 percentage points from 33.01% a year earlier, according to the shareholding pattern filed with NSE.
What are the Global Health latest quarterly results?
Global Health's latest results are for Q1 FY27 (April–June 2026), filed on 30 July 2026: consolidated net profit attributable to shareholders ₹159 crore, down 0.2% from ₹159 crore in Q1 FY26; revenue from operations ₹1,304 crore, up 26.5% year on year.
How does Global Health compare with its peers?
On FY26 consolidated figures, against Max Healthcare Institute, Apollo Hospitals Enterprise and Fortis Healthcare: Global Health's operating margin of 15.8% is the third highest of the four (Max Healthcare Institute 21.5%, Apollo Hospitals Enterprise 11.5%, Fortis Healthcare 17.9%; peer average 16.9%); its revenue growth over three years of 17.9% a year is the second highest of the four (Max Healthcare Institute 22.4% a year, Apollo Hospitals Enterprise 14.9% a year, Fortis Healthcare 13.2% a year; peer average 16.8% a year).
How does the Global Health PE ratio compare with its peers?
At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Global Health's PE ratio is 62.8, the highest of the four: Max Healthcare Institute 57.4, Apollo Hospitals Enterprise 60.7 and Fortis Healthcare 54.7, a peer average of 57.6. Each is the company's market capitalisation at that price divided by its FY26 net profit.
Global Health vs Max Healthcare Institute: how do they compare?
In FY26, Global Health earned net profit attributable to shareholders of ₹556 crore on revenue of ₹4,410 crore, against ₹1,442 crore on ₹8,373 crore for Max Healthcare Institute. Global Health's operating margin was 15.8% (Max Healthcare Institute 21.5%). At the 29 October 2026 close, Global Health's market capitalisation was ₹34,932 crore against ₹82,837 crore for Max Healthcare Institute, and its PE ratio on FY26 profit 62.8 against 57.4.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
